Singapore markets closed
Straits Times Index
3,293.13 +20.41 (+0.62%) S&P 500
5,070.55 +59.95 (+1.20%) Dow
38,503.69 +263.71 (+0.69%) Nasdaq
15,696.64 +245.33 (+1.59%) Bitcoin USD
66,678.48 +547.52 (+0.83%) CMC Crypto 200
1,436.75 +12.65 (+0.89%)
Edwards Lifesciences Corporation (EW)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 52.82B |
| Enterprise value | 51.87B |
| Trailing P/E | 38.15 |
| Forward P/E | 32.05 |
| PEG ratio (5-yr expected) | 5.04 |
| Price/sales (ttm) | 8.91 |
| Price/book (mrq) | 7.94 |
| Enterprise value/revenue | 8.64 |
| Enterprise value/EBITDA | 29.46 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.07 |
| 52-week change 3 | 0.39% |
| S&P500 52-week change 3 | 25.01% |
| 52-week high 3 | 96.12 |
| 52-week low 3 | 60.57 |
| 50-day moving average 3 | 90.01 |
| 200-day moving average 3 | 78.72 |
Share statistics
| Avg vol (3-month) 3 | 4.01M |
| Avg vol (10-day) 3 | 2.89M |
| Shares outstanding 5 | 601.93M |
| Implied shares outstanding 6 | 601.93M |
| Float 8 | 595.33M |
| % held by insiders 1 | 0.89% |
| % held by institutions 1 | 84.05% |
| Shares short (28 Mar 2024) 4 | 10.38M |
| Short ratio (28 Mar 2024) 4 | 2.57 |
| Short % of float (28 Mar 2024) 4 | 1.74% |
| Short % of shares outstanding (28 Mar 2024) 4 | 1.73% |
| Shares short (prior month 29 Feb 2024) 4 | 8.44M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 3:1 |
| Last split date 3 | 01 Jun 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 23.35% |
| Operating margin (ttm) | 39.40% |
Management effectiveness
| Return on assets (ttm) | 12.25% |
| Return on equity (ttm) | 22.34% |
Income statement
| Revenue (ttm) | 6B |
| Revenue per share (ttm) | 9.90 |
| Quarterly revenue growth (yoy) | 13.80% |
| Gross profit (ttm) | N/A |
| EBITDA | 1.87B |
| Net income avi to common (ttm) | 1.4B |
| Diluted EPS (ttm) | 2.30 |
| Quarterly earnings growth (yoy) | -7.20% |
Balance sheet
| Total cash (mrq) | 1.64B |
| Total cash per share (mrq) | 2.73 |
| Total debt (mrq) | 694.9M |
| Total debt/equity (mrq) | 10.34% |
| Current ratio (mrq) | 3.38 |
| Book value per share (mrq) | 11.06 |
Cash flow statement
| Operating cash flow (ttm) | 895.8M |
| Levered free cash flow (ttm) | 751.03M |
© 2024 Yahoo. All rights reserved.